Literature DB >> 7695267

Effect of magnesium complexation by fluoroquinolones on their antibacterial properties.

S Lecomte1, M H Baron, M T Chenon, C Coupry, N J Moreau.   

Abstract

By using infrared and 19F nuclear magnetic resonance spectroscopies, we localized the binding site and measured the affinity of magnesium for six fluoroquinolones. It was proven that magnesium is situated between the ketone and the carboxylate groups. We determined the binding constants for the 1:1 Mg(2+)-drug complex in solution. Sparfloxacin and pefloxacin, with affinity constants (Ka) of (10.1 +/- 0.6) x 10(2) M-1 and (21 +/- 1) x 10(2) M-1, respectively, were the least and the most bound, respectively. The trend of the affinities of the assayed fluoroquinolones for magnesium was correlated with their antimicrobial activities against four bacteria and with their accumulation by these bacteria. The reference strain, Escherichia coli KL16, and two resistant mutants, NalA (gyrase mutation) and NalB (uptake defect), plus Staphylococcus aureus 209P were used. It appeared that, in every case, an impairment of accumulation is responsible for the increase in the MICs observed upon the addition of magnesium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695267      PMCID: PMC188290          DOI: 10.1128/AAC.38.12.2810

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.

Authors:  L L Shen; L A Mitscher; P N Sharma; T J O'Donnell; D W Chu; C S Cooper; T Rosen; A G Pernet
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

Review 2.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 3.  Magnesium transport across cell membranes.

Authors:  P W Flatman
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

4.  Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Authors:  L L Shen; A G Pernet
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.

Authors:  R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors:  M W Hane; T H Wood
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

7.  Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids.

Authors:  K Timmers; R Sternglanz
Journal:  Bioinorg Chem       Date:  1978-08

8.  Routes of quinolone permeation in Escherichia coli.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

9.  Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.

Authors:  S Tornaletti; A M Pedrini
Journal:  Biochim Biophys Acta       Date:  1988-03-31

10.  Interactions between fluoroquinolones, Mg2+, DNA and DNA gyrase, studied by phase partitioning in an aqueous two-phase system and by affinity chromatography.

Authors:  S B Khac; N J Moreau
Journal:  J Chromatogr A       Date:  1994-05-06       Impact factor: 4.759

View more
  15 in total

1.  Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet.

Authors:  M Shakibaei; K Pfister; R Schwabe; J Vormann; R Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.

Authors:  Xiao-Su Pan; Katherine A Gould; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Quinolones sensitize gram-negative bacteria to antimicrobial peptides.

Authors:  Miguel A Campos; Pau Morey; José A Bengoechea
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.

Authors:  Kerstin Pfister; Dago Mazur; Jürgen Vormann; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

5.  MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.

Authors:  W Mao; M S Warren; A Lee; A Mistry; O Lomovskaya
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

6.  Lack of interaction of fluoroquinolones with lipopolysaccharides.

Authors:  B Lindner; A Wiese; K Brandenburg; U Seydel; A Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

7.  Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.

Authors:  R Stahlmann; U Zippel; C Förster; R Schwabe; M Shakibaei; H J Merker; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Mode of action of sulfanilyl fluoroquinolones.

Authors:  F Alovero; M Nieto; M R Mazzieri; R Then; R H Manzo
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.

Authors:  Sonja Hansen; Kim Lewis; Marin Vulić
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

10.  Synthesis, characterization, antibacterial and anti-inflammatory activities of enoxacin metal complexes.

Authors:  Saeed Arayne; Najma Sultana; Urooj Haroon; M Ahmed Mesaik
Journal:  Bioinorg Chem Appl       Date:  2009-08-02       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.